Shares of SpaceX and Moderna have been among the top performers in the market capitalisation stakes, with investors reacting to various economic indicators. According to data from Refinitiv, SpaceX's market capitalisation has surpassed $200 billion for the first time.
This marks a significant milestone for the private space exploration company, which has been experiencing rapid growth in recent years. Moderna, on the other hand, saw its share price surge due to strong demand for its COVID-19 vaccine. The company's stock price has risen by over 10% in the past week alone.
However, not all investors are optimistic about the current market trends. With ongoing economic uncertainty and concerns about inflation, many remain cautious about making significant investments.
As a result, both SpaceX and Moderna's share prices have seen significant fluctuations throughout the day. While some analysts believe that these companies will continue to see growth in the coming months, others are more pessimistic about their prospects.